| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 06/05/1996 | EP0714437A1 Dna encoding inward rectifier, g-protein activated, mammalian, potassium kga channel and uses thereof |
| 06/05/1996 | EP0714435A1 Pro-urokinase mutants |
| 06/05/1996 | EP0714412A1 Heparin functional affinity supports |
| 06/05/1996 | EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 06/05/1996 | EP0714408A1 Tryptase inhibitor |
| 06/05/1996 | EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 06/05/1996 | EP0714406A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 06/05/1996 | EP0714405A1 Therapeutic and diagnostic agents for amyloidosis |
| 06/05/1996 | EP0714404A1 Anti-inflammatory peptides |
| 06/05/1996 | EP0714403A1 Aqueous multiple-phase isolation of polypeptide |
| 06/05/1996 | EP0714401A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8 |
| 06/05/1996 | EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 06/05/1996 | EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
| 06/05/1996 | EP0714307A1 Vaccine compositions |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/05/1996 | EP0586596A4 Device and method for the analysis of rolling blood leukocytes and identifying inhibitors and promoters |
| 06/05/1996 | EP0577705B1 Method of enzymatic preparation of macrolactone |
| 06/05/1996 | EP0465560B1 VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS |
| 06/05/1996 | EP0312542B1 Gamma, delta t cell receptor and methods for detection |
| 06/05/1996 | CN1124040A Adenoviral vectors of animal origin and use thereof in gene therapy |
| 06/05/1996 | CN1031943C Method of purifying protein |
| 06/04/1996 | US5523395 Detecting sialic acids such as n-acetylneuraminic acid and n-glycolylneuraminic acid and their complex sugars |
| 06/04/1996 | US5523393 BCL-2 proteins |
| 06/04/1996 | US5523391 For treating leukemia, uterine cancer |
| 06/04/1996 | US5523290 Antiproliferation factor |
| 06/04/1996 | US5523288 Concurrently administering protein product and polymyxin b to treat infections caused by escherichia, providencia or pseudomonas species |
| 06/04/1996 | US5523287 Thrombin-inhibitory protein from assassin bugs |
| 06/04/1996 | US5523286 Stroma-derived proteoglycan containing composition which promotes differentiation and maintains the self-renewal capacity of long-term bone marrow culture-initiating cells |
| 06/04/1996 | US5523237 Protein preparations |
| 06/04/1996 | US5523227 Gene actiavators |
| 06/04/1996 | US5523215 Culturing host cell expressing desired protein in medium containing copper ions, disrupting, incubating insoluble fraction with chaotropic agent to dissolve contaminants, separating, treating insoluble fraction with reducing agent |
| 06/04/1996 | US5523211 Subjecting to hydrolysis with a proteolytic enzyme and to high performance anion-exchange liquid chromatography |
| 06/04/1996 | US5523209 Culturing a cell expressing a chimeric integrin and contacting with ligand that binds to reporter integrin only when activated |
| 06/04/1996 | US5523089 Borrelia antigen |
| 06/04/1996 | US5523088 Inactivated avian polyomavirus vaccine in psittacine birds |
| 06/04/1996 | CA2059541C Method of preparing a plasmid having both the ability to express a retroviral gene and the ability to process expression products after translation, the resultant plasmid and expression products thereof |
| 06/02/1996 | CA2164165A1 Composition for prophlaxis or treatment of pulmonary circulatory diseases |
| 05/31/1996 | CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties |
| 05/30/1996 | WO1996016184A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 05/30/1996 | WO1996016182A2 Microspore-specific regulatory element |
| 05/30/1996 | WO1996016181A1 Expression plasmids for yeasts |
| 05/30/1996 | WO1996016180A1 Production of variant nisin |
| 05/30/1996 | WO1996016178A1 Immunogens for stimulating mucosal immunity |
| 05/30/1996 | WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
| 05/30/1996 | WO1996016175A2 Lgmd gene coding for a calcium dependent protease |
| 05/30/1996 | WO1996016173A2 Modified proteinase inhibitors |
| 05/30/1996 | WO1996016172A2 Modulators of anchoring protein function |
| 05/30/1996 | WO1996016171A1 Toxins from the wasp bracon hebetor |
| 05/30/1996 | WO1996016170A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 05/30/1996 | WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | WO1996016168A1 Chemical modification of repetitive polymers to enhance water solubility |
| 05/30/1996 | WO1996016167A1 An endoprotease with a new cleavage specificity |
| 05/30/1996 | WO1996016088A1 Protein affecting katp channels |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/30/1996 | WO1996016086A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 05/30/1996 | WO1996016085A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 05/30/1996 | WO1996016084A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 05/30/1996 | WO1996016083A1 Peptides endowed with antiinflammatory activity |
| 05/30/1996 | WO1996016082A1 Novel polypeptides |
| 05/30/1996 | WO1996016075A1 Antibiotic cryptdin peptides and methods of their use |
| 05/30/1996 | WO1996015816A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 05/30/1996 | WO1996015813A1 Cell compositions for use in transplantation and ex vivo gene therapy |
| 05/30/1996 | WO1996015812A1 Use of neuregulins as modulators of cellular communication |
| 05/30/1996 | WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency |
| 05/30/1996 | WO1996015804A1 Acylated insulin analogs |
| 05/30/1996 | WO1996015803A1 SELECTIVE ACYLATION OF ε-AMINO GROUPS |
| 05/30/1996 | WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 05/30/1996 | WO1996015801A1 Human calcium sensor protein, fragments thereof and dna encoding same |
| 05/30/1996 | WO1996015800A1 Method for treating secondary immunodeficiency |
| 05/30/1996 | WO1996015799A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 05/30/1996 | WO1996015780A1 Compositions and methods for preventing and treating allograft rejection |
| 05/30/1996 | WO1996015779A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 05/30/1996 | WO1996015777A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 05/30/1996 | WO1996015758A2 Methods for stimulating erythropoiesis using thrombopoietin |
| 05/30/1996 | WO1996012807A3 Hepatitis e virus antigens and uses therefor |
| 05/30/1996 | WO1996010427A3 Cellular attachment to trans-epithelial appliances |
| 05/30/1996 | WO1996005300A3 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 05/30/1996 | DE4442179A1 Pathogenresistente Pflanzen und Verfahren zu ihrer Herstellung Pathogen-resistant plants and methods for their preparation |
| 05/30/1996 | DE4431121A1 Prodn. of conformation-stabilised calcitonin derivs. having increased activity |
| 05/30/1996 | CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4 |
| 05/30/1996 | CA2205648A1 Human calcium sensor protein, fragments thereof and dna encoding same |
| 05/30/1996 | CA2205540A1 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 05/30/1996 | CA2205532A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 05/30/1996 | CA2205356A1 Modified proteinase inhibitors |
| 05/30/1996 | CA2205219A1 Chemical modification of repetitive polymers to enhance water solubility |
| 05/30/1996 | CA2205204A1 Production of variant nisin |
| 05/30/1996 | CA2205130A1 Immunogens for stimulating mucosal immunity |
| 05/30/1996 | CA2205061A1 Selective acylation of .epsilon.-amino groups |
| 05/30/1996 | CA2205060A1 Acylated insulin analogs |
| 05/30/1996 | CA2204995A1 Antibiotic cryptdin peptides and methods of their use |
| 05/30/1996 | CA2204850A1 Use of neuregulins as modulators of cellular communication |
| 05/30/1996 | CA2204524A1 Toxins from the wasp bracon hebetor |
| 05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | CA2204252A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems |
| 05/30/1996 | CA2204147A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 05/30/1996 | CA2181826A1 Modulators of anchoring protein function |
| 05/30/1996 | CA2163700A1 Method for the extraction of glicentin or glicentin analogous substances |
| 05/29/1996 | EP0713918A2 Method for the extraction of glicentin or glicentin analagous substances |
| 05/29/1996 | EP0713915A1 Hog cholera virus vaccine and diagnostic |